Search Results - "KOIKE, Ryuji"

Refine Results
  1. 1

    Japan College of Rheumatology guideline for the use of methotrexate in patients with rheumatoid arthritis by Kameda, Hideto, Fujii, Takao, Nakajima, Ayako, Koike, Ryuji, Sagawa, Akira, Kanbe, Katsuaki, Tomita, Tetsuya, Harigai, Masayoshi, Suzuki, Yasuo

    Published in Modern rheumatology (02-01-2019)
    “…Methotrexate (MTX), the anchor drug in the current treatment strategy for rheumatoid arthritis (RA), was first approved for treatment of RA in Japan in 1999 at…”
    Get full text
    Journal Article
  2. 2

    blaKPC-2-Encoding IncP-6 Plasmids in Citrobacter freundii and Klebsiella variicola Strains from Hospital Sewage in Japan by Ota, Yusuke, Prah, Isaac, Nukui, Yoko, Koike, Ryuji, Saito, Ryoichi

    Published in Applied and environmental microbiology (26-04-2022)
    “…Klebsiella pneumoniae carbapenemase (KPC) producers are an emerging threat to global health, and the hospital water environment is considered an important…”
    Get full text
    Journal Article
  3. 3

    Novel insights into genetic characteristics of blaGES-encoding plasmids from hospital sewage by Ota, Yusuke, Prah, Isaac, Mahazu, Samiratu, Gu, Yoshiaki, Nukui, Yoko, Koike, Ryuji, Saito, Ryoichi

    Published in Frontiers in microbiology (17-08-2023)
    “…Introduction The prevalence of Guiana extended-spectrum (GES)-type carbapenemase producers is increasing worldwide, and hospital water environments are…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis by Yokoyama-Kokuryo, Waka, Yamazaki, Hayato, Takeuchi, Tsutomu, Amano, Koichi, Kikuchi, Jun, Kondo, Tsuneo, Nakamura, Seiji, Sakai, Ryoko, Hirano, Fumio, Nanki, Toshihiro, Koike, Ryuji, Harigai, Masayoshi

    Published in Arthritis research & therapy (12-03-2020)
    “…Abatacept (ABA) is a biological disease-modifying antirheumatic drug (bDMARD) for rheumatoid arthritis (RA). The aim of this study was to identify molecules…”
    Get full text
    Journal Article
  6. 6

    Evaluation of polymerase chain reaction-based open reading frame typing method for the clonality investigation of Clostridioides difficile isolates by Ota, Yusuke, Hongou, Natsune, Nukui, Yoko, Koike, Ryuji, Tohda, Shuji, Saito, Ryoichi

    Published in Anaerobe (01-12-2021)
    “…Here, we assessed the utility of a polymerase chain reaction-based open reading frame typing assay for investigating the clonality of Clostridioides difficile…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Higher risk of hospitalized infection, cardiovascular disease, and fracture in patients with rheumatoid arthritis determined using the Japanese health insurance database by Kasai, Shoko, Sakai, Ryoko, Koike, Ryuji, Kohsaka, Hitoshi, Miyasaka, Nobuyuki, Harigai, Masayoshi

    Published in Modern rheumatology (03-09-2019)
    “…Objective: To evaluate the risk of hospitalized infection (HI), cardiovascular disease (CVD), stroke, and fracture in rheumatoid arthritis (RA) patients…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Molecular epidemiologic and clinical analysis of Helicobacter cinaedi bacteremia in Japan by Nukui, Yoko, Chino, Takashi, Tani, Chihiro, Sonobe, Kazunari, Aiso, Yoshibumi, Tohda, Shuji, Koike, Ryuji, Saito, Ryoichi

    Published in Helicobacter (Cambridge, Mass.) (01-02-2020)
    “…Background Helicobacter cinaedi is an important pathogen that causes bloodstream infections. Owing to the challenges in its culture and identification, its…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis by Koike, Ryuji, Takeuchi, Tsutomu, Eguchi, Katsumi, Miyasaka, Nobuyuki

    Published in Modern rheumatology (01-12-2007)
    “…Application of biological agents targeting tumor necrosis factor-alpha (TNF-alpha) caused a paradigm shift in the treatment of rheumatoid arthritis (RA). The…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Study protocol: a multicenter, uncontrolled, open-label study of palivizumab in neonates, infants, and preschool children at high risk of severe respiratory syncytial virus infection by Mori, Masaaki, Watabe, Shinichi, Taguchi, Tomoaki, Hasegawa, Hisaya, Ishige, Mika, Tanuma, Naoyuki, Hirakawa, Akihiro, Koike, Ryuji, Kusuda, Satoshi

    Published in BMC pediatrics (02-03-2021)
    “…The prophylactic use of anti-respiratory syncytial virus (RSV) antibody (palivizumab) for severe RSV infection is not approved in Japan in specified groups of…”
    Get full text
    Journal Article
  17. 17

    Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis by Koike, Ryuji, Harigai, Masayoshi, Atsumi, Tatsuya, Amano, Koichi, Kawai, Shinichi, Saito, Kazuyoshi, Saito, Tomoyuki, Yamamura, Masahiro, Matsubara, Tsukasa, Miyasaka, Nobuyuki

    Published in Modern rheumatology (01-08-2009)
    “…The introduction of biological agents targeting tumor necrosis factor-alpha (TNF-α) has brought about a paradigm shift in the treatment of rheumatoid arthritis…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20